DEA Approves Synthetic Cannabis Medication by Anti-Cannabis Pharmaceutical Giant
Mon / Mar 27th
The Drug Enforcement Administration has approved Syndros, a cannabis-based medication developed by pharmaceutical company Insys Therapeutics, for Schedule II status under the… Read More